These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 17085491

  • 1. On the lower susceptibility of oseltamivir to influenza neuraminidase subtype N1 than those in N2 and N9.
    Aruksakunwong O, Malaisree M, Decha P, Sompornpisut P, Parasuk V, Pianwanit S, Hannongbua S.
    Biophys J; 2007 Feb 01; 92(3):798-807. PubMed ID: 17085491
    [Abstract] [Full Text] [Related]

  • 2. Understanding of known drug-target interactions in the catalytic pocket of neuraminidase subtype N1.
    Malaisree M, Rungrotmongkol T, Decha P, Intharathep P, Aruksakunwong O, Hannongbua S.
    Proteins; 2008 Jun 01; 71(4):1908-18. PubMed ID: 18175324
    [Abstract] [Full Text] [Related]

  • 3. Infiltration of water molecules into the oseltamivir-binding site of H274Y neuraminidase mutant causes resistance to oseltamivir.
    Park JW, Jo WH.
    J Chem Inf Model; 2009 Dec 01; 49(12):2735-41. PubMed ID: 19957991
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mutation-induced loop opening and energetics for binding of tamiflu to influenza N8 neuraminidase.
    Kar P, Knecht V.
    J Phys Chem B; 2012 May 31; 116(21):6137-49. PubMed ID: 22553951
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus.
    Du QS, Wang SQ, Chou KC.
    Biochem Biophys Res Commun; 2007 Oct 19; 362(2):525-31. PubMed ID: 17707775
    [Abstract] [Full Text] [Related]

  • 11. Discovery of N-substituted oseltamivir derivatives as potent and selective inhibitors of H5N1 influenza neuraminidase.
    Xie Y, Xu D, Huang B, Ma X, Qi W, Shi F, Liu X, Zhang Y, Xu W.
    J Med Chem; 2014 Oct 23; 57(20):8445-58. PubMed ID: 25255388
    [Abstract] [Full Text] [Related]

  • 12. Insights from modeling the 3D structure of H5N1 influenza virus neuraminidase and its binding interactions with ligands.
    Wei DQ, Du QS, Sun H, Chou KC.
    Biochem Biophys Res Commun; 2006 Jun 09; 344(3):1048-55. PubMed ID: 16647045
    [Abstract] [Full Text] [Related]

  • 13. Comment on 'Comment on "Another look at the molecular mechanism of the resistance of H5N1 influenza A virus neuraminidase (NA) to oseltamivir (OTV)"'.
    Mitrasinovic PM.
    Biophys Chem; 2011 Mar 09; 154(2-3):102. PubMed ID: 21316835
    [No Abstract] [Full Text] [Related]

  • 14. Dynamic behavior of avian influenza A virus neuraminidase subtype H5N1 in complex with oseltamivir, zanamivir, peramivir, and their phosphonate analogues.
    Udommaneethanakit T, Rungrotmongkol T, Bren U, Frecer V, Stanislav M.
    J Chem Inf Model; 2009 Oct 09; 49(10):2323-32. PubMed ID: 19780597
    [Abstract] [Full Text] [Related]

  • 15. Insights into susceptibility of antiviral drugs against the E119G mutant of 2009 influenza A (H1N1) neuraminidase by molecular dynamics simulations and free energy calculations.
    Pan P, Li L, Li Y, Li D, Hou T.
    Antiviral Res; 2013 Nov 09; 100(2):356-64. PubMed ID: 24055835
    [Abstract] [Full Text] [Related]

  • 16. The hydrophobic side chain of oseltamivir influences type A subtype selectivity of neuraminidase inhibitors.
    Lin X, Qin-Hua C, Peng L, Chun-Lei L, Guang-De Y.
    Chem Biol Drug Des; 2018 Jan 09; 91(1):105-115. PubMed ID: 28646621
    [Abstract] [Full Text] [Related]

  • 17. Study of drug resistance of chicken influenza A virus (H5N1) from homology-modeled 3D structures of neuraminidases.
    Wang SQ, Du QS, Chou KC.
    Biochem Biophys Res Commun; 2007 Mar 16; 354(3):634-40. PubMed ID: 17266937
    [Abstract] [Full Text] [Related]

  • 18. Computational design of novel, high-affinity neuraminidase inhibitors for H5N1 avian influenza virus.
    Park JW, Jo WH.
    Eur J Med Chem; 2010 Feb 16; 45(2):536-41. PubMed ID: 19914748
    [Abstract] [Full Text] [Related]

  • 19. Binding pattern of the long acting neuraminidase inhibitor laninamivir towards influenza A subtypes H5N1 and pandemic H1N1.
    Meeprasert A, Khuntawee W, Kamlungsua K, Nunthaboot N, Rungrotmongkol T, Hannongbua S.
    J Mol Graph Model; 2012 Sep 16; 38():148-54. PubMed ID: 23079644
    [Abstract] [Full Text] [Related]

  • 20. Novel binding patterns between ganoderic acids and neuraminidase: Insights from docking, molecular dynamics and MM/PBSA studies.
    Yang Z, Wu F, Yuan X, Zhang L, Zhang S.
    J Mol Graph Model; 2016 Apr 16; 65():27-34. PubMed ID: 26905206
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.